ArticleAnnals of clinical microbiology and antimicrobials2014

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome.

Doron Boltin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.